- Home
- ABSI vs NNOX Comparison
ABSI vs NNOX Comparison
Compare ABSI & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- NNOX
- Stock Information
- Founded
- ABSI 2011
- NNOX 2011
- Country
- ABSI United States
- NNOX Israel
- Employees
- ABSI N/A
- NNOX N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- ABSI Health Care
- NNOX Health Care
- Exchange
- ABSI Nasdaq
- NNOX Nasdaq
- Market Cap
- ABSI 338.0M
- NNOX 248.7M
- IPO Year
- ABSI 2021
- NNOX 2020
- Fundamental
- Price
- ABSI $2.39
- NNOX $3.85
- Analyst Decision
- ABSI Strong Buy
- NNOX Strong Buy
- Analyst Count
- ABSI 5
- NNOX 2
- Target Price
- ABSI $7.98
- NNOX $8.50
- AVG Volume (30 Days)
- ABSI 4.4M
- NNOX 1.3M
- Earning Date
- ABSI 08-12-2025
- NNOX 08-12-2025
- Dividend Yield
- ABSI N/A
- NNOX N/A
- EPS Growth
- ABSI N/A
- NNOX N/A
- EPS
- ABSI N/A
- NNOX N/A
- Revenue
- ABSI $4,138,000.00
- NNOX $11,886,000.00
- Revenue This Year
- ABSI $44.71
- NNOX $24.12
- Revenue Next Year
- ABSI $374.26
- NNOX $160.56
- P/E Ratio
- ABSI N/A
- NNOX N/A
- Revenue Growth
- ABSI 27.32
- NNOX 17.36
- 52 Week Low
- ABSI $2.01
- NNOX $3.75
- 52 Week High
- ABSI $6.33
- NNOX $11.00
- Technical
- Relative Strength Index (RSI)
- ABSI 33.33
- NNOX 32.78
- Support Level
- ABSI $2.50
- NNOX $3.88
- Resistance Level
- ABSI $2.73
- NNOX $4.16
- Average True Range (ATR)
- ABSI 0.18
- NNOX 0.19
- MACD
- ABSI -0.04
- NNOX -0.02
- Stochastic Oscillator
- ABSI 1.94
- NNOX 8.44
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.